Documented Delays in EU Approval of GM Products
EuropaBio has released a document on Undue Delays in the EU Approval of Safe GM Products. It contains a list of product applications in the decision making phase of the EU approval process. Results show that there is inconsistency between legally prescribed timelines and the administrative practice.
The document cites the example of 1507 maize for cultivation that had an EFSA approval in 2005 and is still waiting for the Commission to schedule a vote in the Appeal Committee despite a maximum two months processing time. It had already been delayed earlier when it took 1452 days for the Commission to schedule a vote at the committee level (maximum days set at 3 months).
Download a copy of the document at http://www.europabio.org/sites/default/files/position/gm_approvals_status_february_2012.pdf
This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA)
View Crop Biotech Update (
February 17, 2012
) Newsletter
Subscribe to Crop Biotech Update Newsletter
Crop Biotech Update Archive
Crop Biotech Update RSS
Biofuels Supplement RSS
